FINWIRES · TerminalLIVE
FINWIRES

Update: Market Chatter: World Bank to Cut Off China Loans by 2031

By

(Updates to add comment from a spokesperson for China's embassy in the U.S. in the last paragraph)

The World Bank plans to gradually end new lending to China by 2031, limiting financing at $2 billion through that date, Reuters reported Wednesday, citing sources familiar with the plan.

While no formal vote is mandated, the World Bank's board plans to review the initiative during the seven-day period beginning July 20, according to the report.

This decision, part of a new five-year partnership framework, reflects China's transformation into the world's second-largest economy, Reuters wrote. Annual lending to China has already fallen to $750 million in 2025 from $2.4 billion in 2017.

A World Bank official said China's development in recent decades is "significant," and the institution is now transitioning to a renewed relationship recognizing this evolved reality, according to the report.

A spokesperson for China's embassy in the U.S., in an emailed response to' request for comment, said that "the scale of World Bank lending to China has gradually declined in recent years," which resulted from the changes in domestic demand and cooperation between China and the World Bank.

As it looks ahead, "China will continue to strengthen cooperation with the World Bank in addressing global challenges," according to the spokesperson.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Related Articles

Asia

SSY Gets China Production Nod for Methocarbamol Tablets, Registers Phloroglucinol Dihydrate

SSY Group (HKG:2005) obtained production and registration approval for Methocarbamol Tablets and registration approval for Phloroglucinol Dihydrate from China's National Medical Products Administration, according to a Thursday Hong Kong bourse filing.The approval for Methocarbamol Tablets came as the drug passed the regulator's consistency evaluation.Methocarbamol Tablets are muscle relaxants mainly used to treat joint and muscle sprains, lumbar muscle strain, and sciatica.Phloroglucinol Dihydrate is used to treat acute spasmodic pain associated with digestive, biliary, urinary, and gynecological conditions.Shares of the firm were up nearly 5% in late morning trade on Thursday.

HKG:2005
Asia

Bellavista Resources Starts Drilling at Canada, Western Australia Projects; Shares Gain 3%

Bellavista Resources (ASX:BVR) started drilling the Pickle Crow gold project in Canada and at its Brumby project in Western Australia, according to a Thursday filing with the Australian bourse.Initial drilling at Pickle Crow for the remainder of the year will assess the open-pit potential on the existing mineral resource of 2.7 million ounces at 7.2 grams per tonne grade of gold, before moving to additional near-surface regional targets in early 2027.At Brumby, the company will assess mineralization continuity for a potential future resource definition drilling program, alongside column leach test work.Bellavista Resources shares gained 3% in recent Thursday trade.

ASX:BVR
Asia

Binastra Unit Bags MYR491 Million Data Center Development Deal

Binastra (KLSE: BNASTRA) unit Binastra Builders secured a 491.2 million ringgit turnkey contract to develop a seven-story data center in Kuala Lumpur, according to a Wednesday Bursa Malaysia filing.The contract, awarded by Exsim Sri Permai, covers the design, construction, testing, commissioning, maintenance and guarantee works, including foundation, substructure, main building and infrastructure works.The project, which also includes a guardhouse, refuse room and electrical substation, is scheduled to begin on July 1 and be completed within 18 months.

KLSE:BNASTRA